Biophore receives sub-license from MPP to manufacture and market molnupiravir for COVID treatment
Hyderabad, 20 January 2022: Biophore India Pharmaceuticals has announced that it has received a license from Medicines Patent Pool (MPP)...
Biophore
Biophore to manufacture indigenous ingredients of Pfizer’s COVID drug
Hyderabad, January 19, 2022: Biophore India Pharmaceuticals has today announced that they have developed and started manufacturing the key intermediates...